- Home
- JAZZ vs CIG Comparison
JAZZ vs CIG Comparison
Compare JAZZ & CIG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JAZZ
- CIG
- Stock Information
- Founded
- JAZZ 2003
- CIG 1952
- Country
- JAZZ Ireland
- CIG Brazil
- Employees
- JAZZ N/A
- CIG N/A
- Industry
- JAZZ Biotechnology: Pharmaceutical Preparations
- CIG Electric Utilities: Central
- Sector
- JAZZ Health Care
- CIG Utilities
- Exchange
- JAZZ Nasdaq
- CIG Nasdaq
- Market Cap
- JAZZ 6.1B
- CIG 4.9B
- IPO Year
- JAZZ 2007
- CIG N/A
- Fundamental
- Price
- JAZZ $102.78
- CIG $1.75
- Analyst Decision
- JAZZ Strong Buy
- CIG
- Analyst Count
- JAZZ 13
- CIG 0
- Target Price
- JAZZ $187.15
- CIG N/A
- AVG Volume (30 Days)
- JAZZ 1.6M
- CIG 3.7M
- Earning Date
- JAZZ 04-30-2025
- CIG 05-09-2025
- Dividend Yield
- JAZZ N/A
- CIG 11.65%
- EPS Growth
- JAZZ 41.75
- CIG 60.51
- EPS
- JAZZ 8.65
- CIG 0.40
- Revenue
- JAZZ $4,068,950,000.00
- CIG $6,438,199,502.00
- Revenue This Year
- JAZZ $7.60
- CIG N/A
- Revenue Next Year
- JAZZ $3.43
- CIG $4.76
- P/E Ratio
- JAZZ $11.88
- CIG $4.99
- Revenue Growth
- JAZZ 6.12
- CIG 8.06
- 52 Week Low
- JAZZ $95.49
- CIG $1.59
- 52 Week High
- JAZZ $148.06
- CIG $2.19
- Technical
- Relative Strength Index (RSI)
- JAZZ 31.87
- CIG 48.14
- Support Level
- JAZZ $100.42
- CIG $1.69
- Resistance Level
- JAZZ $104.12
- CIG $1.72
- Average True Range (ATR)
- JAZZ 6.41
- CIG 0.06
- MACD
- JAZZ -1.27
- CIG 0.01
- Stochastic Oscillator
- JAZZ 22.51
- CIG 76.19
About JAZZ Jazz Pharmaceuticals plc (Ireland)
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.
About CIG Comp En De Mn Cemig ADS
Cia Energetica DE Minas Gerais - Cemig Formerly Energy Company of Minas Gerais is a Brazilian power company that generates, transmits, and distributes electricity. As one of the largest power companies in Brazil, the firm operates across most Brazilian states and Chile. The company has various subsidiaries and operates chiefly through its generation, transmission, distribution, and gas segments. The majority of the company's revenue is derived from electricity sales to consumers. The company generates power primarily through hydroelectric resources and secondarily through thermal and wind resources.